Literature DB >> 23751834

Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain".

Jordan Sorokin1, Babak Saboury, JinHyung Albert Ahn, Mateen Moghbel, Sandip Basu, Abass Alavi.   

Abstract

PURPOSE: With its unique ability to assess function through metabolism, FDG PET may provide key insight into the adverse effects of chemotherapy on the brain by shedding light on its cognitive and psychological consequences, a well-known phenomenon in cancer patients who undergo such treatments. PATIENTS AND METHODS: Twenty-one patients with untreated non-Hodgkin lymphoma and no involvement of the central nervous system were selected from an existing database for this investigation. An adaptive threshold imaging software called ROVER was used to analyze and quantify FDG PET scans for assessing whole-brain metabolism. A 3D spherical region of interest was drawn surrounding the cerebral cortex, excluding subcortical and non-cortical areas.
RESULTS: We noted a mean reduction of 1308.86 ± 394.74 SUV-cc (P = 0.03) in the whole-brain cortical glycolysis after standard chemotherapy, which translated to a decrease of 16.9 ± 5.04% (P = 0.03) in the measured structures.
CONCLUSION: These results demonstrate the potential role of such adaptive quantitative techniques in studying underlying biological effects of chemotherapy and offer a promising avenue for future research in this field.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23751834     DOI: 10.1097/RLU.0b013e318292aa81

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  7 in total

1.  Global and regional brain glucose metabolism decline after systemic chemotherapy.

Authors:  Saeid Gholami; Eivind Antonsen Segtnan; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-07       Impact factor: 9.236

2.  Regional changes with global brain hypometabolism indicates a physiological triage phenomenon and can explain shared pathophysiological events in Alzheimer's & small vessel diseases and delirium.

Authors:  Sandeep K Gupta; Natalie Rutherford; Xenia Dolja-Gore; Tahne Watson; Balakrishnan R Nair
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-12-15

3.  Altered Regional Brain Glucose Metabolism in Diffuse Large B-Cell Lymphoma Patients Treated With Cyclophosphamide, Epirubicin, Vincristine, and Prednisone: An Fluorodeoxyglucose Positron Emission Tomography Study of 205 Cases.

Authors:  Yuxiao Hu; Qin Zhang; Can Cui; Yun Zhang
Journal:  Front Neurosci       Date:  2022-06-15       Impact factor: 5.152

Review 4.  Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.

Authors:  Valentina Berti; Lisa Mosconi; Alberto Pupi
Journal:  PET Clin       Date:  2014-04

Review 5.  Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.

Authors:  Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2021-11-02       Impact factor: 5.153

Review 6.  A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue.

Authors:  Jan Petr; Louise Hogeboom; Pavel Nikulin; Evita Wiegers; Gwen Schroyen; Jesper Kallehauge; Marek Chmelík; Patricia Clement; Ruben E Nechifor; Liviu-Andrei Fodor; Philip C De Witt Hamer; Frederik Barkhof; Cyril Pernet; Maarten Lequin; Sabine Deprez; Radim Jančálek; Henk J M M Mutsaerts; Francesca B Pizzini; Kyrre E Emblem; Vera C Keil
Journal:  MAGMA       Date:  2021-12-17       Impact factor: 2.310

7.  Effect of various blood glucose levels on regional FDG uptake in the brain.

Authors:  Ismet Sarikaya; Ahmed N Albatineh; Ali Sarikayaa
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.